Astrocyte Heterogeneity: Impact to Brain Aging and Disease

Overview

Journal Front Aging Neurosci

Specialty Geriatrics

Date 2019 Apr 4

PMID 30941031

Citations 174

Authors

Isadora Matias

Juliana Morgado

Flavia Carvalho Alcantara Gomes

Affiliations

Soon will be listed here.

Abstract

Astrocytes, one of the largest glial cell population in the central nervous system (CNS), play a key function in several events of brain development and function, such as synapse formation and function, control of neurotransmitters release and uptake, production of trophic factors and control of neuronal survival. Initially described as a homogenous population, several evidences have pointed that astrocytes are highly heterogeneous, both morphologically and functionally, within the same region, and across different brain regions. Recent findings suggest that the heterogeneity in the expression profile of proteins involved in astrocyte function may predict the selective vulnerability of brain regions to specific diseases, as well as to the age-related cognitive decline. However, the molecular mechanisms underlying these changes, either in aging as well as in brain disease are scarce. Neuroinflammation, a hallmark of several neurodegenerative diseases and aging, is reported to have a dubious impact on glial activation, as these cells release pro- and anti-inflammatory cytokines and chemokines, anti-oxidants, free radicals, and neurotrophic factors. Despite the emerging evidences supporting that reactive astrocytes have a duality in their phenotype, neurotoxic or neuroprotective properties, depending on the age and stimuli, the underlying mechanisms of their activation, cellular interplays and the impact of regional astrocyte heterogeneity are still a matter of discussion. In this review article, we will summarize recent findings on astrocyte heterogeneity and phenotypes, as well as their likely impact for the brain function during aging and neural diseases. We will focus on the molecules and mechanisms triggered by astrocyte to control synapse formation in different brain regions. Finally, we will discuss new evidences on how the modulation of astrocyte phenotype and function could impact the synaptic deficits and glial dysfunction present in aging and pathological states.

Citing Articles

Lysosomal acidification impairment in astrocyte-mediated neuroinflammation.

Zeng J, Indajang J, Pitt D, Lo C J Neuroinflammation. 2025; 22(1):72.

PMID: 40065324 PMC: 11892208. DOI: 10.1186/s12974-025-03410-w.

New perspectives on heterogeneity in astrocyte reactivity in neuroinflammation.

Santos D, Silva Lima S, Moreira L, Costa S, de Sampaio Schitine C Brain Behav Immun Health. 2025; 44:100948.

PMID: 40028234 PMC: 11871470. DOI: 10.1016/j.bbih.2025.100948.

Protective effects of enzymatically digested velvet antler polypeptides on mitochondria in primary astrocytes.

Paing Y, Lee S J Anim Sci Technol. 2025; 67(1):164-178.

PMID: 39974783 PMC: 11833196. DOI: 10.5187/jast.2023.e135.

Mapping reactive astrogliosis in Parkinson's brain with astroglial tracers BU99008 and Deprenyl: New insights from a multi-marker postmortem study.

Rocha F, Roy A, Varshney M, Kumar A Alzheimers Dement. 2025; 21(2):e14488.

PMID: 39936538 PMC: 11848164. DOI: 10.1002/alz.14488.

The Rise of Pluripotent Stem Cell-Derived Glia Models of Neuroinflammation.

Kala S, Strutz A, Katt M Neurol Int. 2025; 17(1).

PMID: 39852770 PMC: 11767680. DOI: 10.3390/neurolint17010006.

References

Nagy J, Patel D, Ochalski P, Stelmack G . Connexin30 in rodent, cat and human brain: selective expression in gray matter astrocytes, co-localization with connexin43 at gap junctions and late developmental appearance. Neuroscience. 1999; 88(2):447-68. DOI: 10.1016/s0306-4522(98)00191-2. View

Morgan T, Xie Z, Goldsmith S, Yoshida T, Lanzrein A, Stone D . The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction. Neuroscience. 1999; 89(3):687-99. DOI: 10.1016/s0306-4522(98)00334-0. View

Araque A, Parpura V, Sanzgiri R, Haydon P . Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 1999; 22(5):208-15. DOI: 10.1016/s0166-2236(98)01349-6. View

Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H . NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol. 2000; 99(1):14-20. DOI: 10.1007/pl00007400. View

Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E . Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000; 908:244-54. DOI: 10.1111/j.1749-6632.2000.tb06651.x. View

Eng L, Ghirnikar R, Lee Y . Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res. 2000; 25(9-10):1439-51. DOI: 10.1023/a:1007677003387. View

Qu H, Haberg A, Haraldseth O, Unsgard G, Sonnewald U . (13)C MR spectroscopy study of lactate as substrate for rat brain. Dev Neurosci. 2000; 22(5-6):429-36. DOI: 10.1159/000017472. View

Hainfellner J, Voigtlander T, Strobel T, Mazal P, Maddalena A, Aguzzi A . Fibroblasts can express glial fibrillary acidic protein (GFAP) in vivo. J Neuropathol Exp Neurol. 2001; 60(5):449-61. DOI: 10.1093/jnen/60.5.449. View

Bushong E, Martone M, Jones Y, Ellisman M . Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci. 2002; 22(1):183-92. PMC: 6757596. View

10.

Schmitt A, Asan E, Lesch K, Kugler P . A splice variant of glutamate transporter GLT1/EAAT2 expressed in neurons: cloning and localization in rat nervous system. Neuroscience. 2002; 109(1):45-61. DOI: 10.1016/s0306-4522(01)00451-1. View

11.

Nett W, Oloff S, McCarthy K . Hippocampal astrocytes in situ exhibit calcium oscillations that occur independent of neuronal activity. J Neurophysiol. 2002; 87(1):528-37. DOI: 10.1152/jn.00268.2001. View

12.

Grosche J, Kettenmann H, Reichenbach A . Bergmann glial cells form distinct morphological structures to interact with cerebellar neurons. J Neurosci Res. 2002; 68(2):138-49. DOI: 10.1002/jnr.10197. View

13.

Ogata K, Kosaka T . Structural and quantitative analysis of astrocytes in the mouse hippocampus. Neuroscience. 2002; 113(1):221-33. DOI: 10.1016/s0306-4522(02)00041-6. View

14.

Martinez R, Gomes F . Neuritogenesis induced by thyroid hormone-treated astrocytes is mediated by epidermal growth factor/mitogen-activated protein kinase-phosphatidylinositol 3-kinase pathways and involves modulation of extracellular matrix proteins. J Biol Chem. 2002; 277(51):49311-8. DOI: 10.1074/jbc.M209284200. View

15.

Sponne I, Fifre A, Drouet B, Klein C, Koziel V, Pincon-Raymond M . Apoptotic neuronal cell death induced by the non-fibrillar amyloid-beta peptide proceeds through an early reactive oxygen species-dependent cytoskeleton perturbation. J Biol Chem. 2002; 278(5):3437-45. DOI: 10.1074/jbc.M206745200. View

16.

Braak H, Del Tredici K, Rub U, de Vos R, Jansen Steur E, Braak E . Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2002; 24(2):197-211. DOI: 10.1016/s0197-4580(02)00065-9. View

17.

Reilly J, Games D, Rydel R, Freedman S, Schenk D, Young W . Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model. Proc Natl Acad Sci U S A. 2003; 100(8):4837-42. PMC: 153642. DOI: 10.1073/pnas.0330745100. View

18.

Nagele R, DAndrea M, Lee H, Venkataraman V, Wang H . Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Res. 2003; 971(2):197-209. DOI: 10.1016/s0006-8993(03)02361-8. View

19.

Gong Y, Chang L, Viola K, Lacor P, Lambert M, Finch C . Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A. 2003; 100(18):10417-22. PMC: 193576. DOI: 10.1073/pnas.1834302100. View

20.

Dauer W, Przedborski S . Parkinson's disease: mechanisms and models. Neuron. 2003; 39(6):889-909. DOI: 10.1016/s0896-6273(03)00568-3. View